Serviços Personalizados
Journal
Artigo
Português (pdf)
Artigo em XML
Referências do artigo
Tradução automática
Enviar este artigo por emailIndicadores
Citado por SciELO 
Acessos
Links relacionados
Similares em
SciELO
Compartilhar
Permalink
Medicina Interna
versão impressa ISSN 0872-671X
Resumo
ALVES, Sara Carneiro; SANTOS, José Augusto; RODRIGUES, Catarina Ramos e MOURA, Adriana. Evidence of Renin-Angiotensin System Modifiers in the Prevention of Episodic Migraine. Medicina Interna [online]. 2021, vol.28, n.1, pp.52-58. Epub 15-Mar-2021. ISSN 0872-671X. https://doi.org/10.24950/r/190/20/1/2021.
:
Migraine is a common and disabling disease. Experimental models suggest an association between renin-angiotensin system and migraine development. This paper aims to review the evidence of angiotensin inhibitors in reducing migraine episodes.
Methods:
We searched for guidelines, systematic reviews, meta-analysis and randomized controlled trials. Level of evidence and strength of recommendation (SOR) attribution were based on Strength of Recommendation Taxonomy (SORT).
Results:
We identified 63 articles, from which we selected eight: four guidelines, two meta-analysis and two systematic review.
Discussion/Conclusion:
Candesartan 16 mg/day may be used as a preventive treatment of episodic migraine (SOR B), in spite of not being recommended as the first line of treatment. Lisinopril also showed some potential. (SOR B)
Palavras-chave : Angiotensin-Converting Enzyme Inhibitors; Migraine Disorders/prevention & control.
